Lee Ainslie’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,177
Closed -$773K 336
2023
Q2
$773K Buy
+8,177
New +$691K 0.02% 187
2021
Q4
Sell
-10,689
Closed -$529K 367
2021
Q3
$529K Buy
10,689
+10,068
+1,621% +$546K 0.01% 434
2021
Q2
$35K Buy
+621
New +$36.3K ﹤0.01% 635
2021
Q1
Sell
-13,597
Closed -$728K 717
2020
Q4
$728K Sell
13,597
-26,486
-66% -$1.37M 0.01% 288
2020
Q3
$1.88M Buy
40,083
+11,874
+42% +$609K 0.04% 151
2020
Q2
$1.47M Sell
28,209
-18,313
-39% -$944K 0.03% 220
2020
Q1
$2.23M Buy
+46,522
New +$2.42M 0.05% 170

Other funds holding CAH

Lee Ainslie's CAH Position: Q3 2023 in Review

Lee Ainslie sold out of Cardinal Health (CAH) in Q3 2023, closing a stake of 8,177 shares — an estimated $773K sold.

Lee Ainslie first reported a position in CAH in Q1 2020 and held it in 7 quarters. The position peaked at $2.23M in Q1 2020. 949 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Lee Ainslie reported no remaining Cardinal Health position as of Q3 2023 after selling out during the quarter.
  • Lee Ainslie sold 8,177 Cardinal Health shares in Q3 2023, an estimated $773K.
  • Lee Ainslie first reported a position in Cardinal Health in Q1 2020 and held it in 7 quarters.
  • Lee Ainslie's Cardinal Health position peaked at $2.23M in Q1 2020.
  • 949 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Maverick Capital's 13F filing for Q3 2023, filed 14 Nov 2023.